Dr. Grabski discusses why MCC offers significant economic advantages over traditional batch chromatography methods for purification of monoclonal antibodies. Live: Tuesday, Nov. 19, 2019 at 11am EST | 8am PST | 4pm GMT | 5pm CET Register free
Register Free: http://www.biopharminternational.com/bp_w/intensified
Event Overview:
Multi-column continuous chromatography (MCC) offers significant economic advantages over traditional batch chromatography methods for purification of monoclonal antibodies (mAbs), including increased productivity, reduced resin and buffer requirements, and faster process time. The protein A capture step is a primary target to apply MCC due to its high cost, which is driven even higher as improvements in upstream processing have produced a steady increase in mAb titers. The benefits of MCC can also be realized in downstream polishing steps using ion exchange, mixed mode, hydroxyapatite, and hydrophobic interaction chemistries. This webcast will review the key factors in designing an MCC process focusing on protein A capture and ion exchange polishing steps.
Key Learning Objectives:
Speaker: Dr. Anthony Grabski, Director of Research and Development, Semba Biosciences, Inc.
Date and Time: Tuesday, Nov. 19, 2019 at 11am EST | 8am PST | 4pm GMT | 5pm CET
On demand available after final airing until Nov. 19, 2020
Sponsor: Tosoh Bioscience LLC
Register Free: http://www.biopharminternational.com/bp_w/intensified